141 related articles for article (PubMed ID: 34505295)
1. Socioeconomic and racial/ethnic disparities in receipt of palliative care among patients with metastatic hepatocellular carcinoma.
Alterio RE; Ju MR; Wang SC; Mansour JC; Yopp A; Porembka MR
J Surg Oncol; 2021 Dec; 124(8):1365-1372. PubMed ID: 34505295
[TBL] [Abstract][Full Text] [Related]
2. Underutilization of Palliative Care in Metastatic Foregut Cancer Patients Is Associated with Socioeconomic Disparities.
Ju MR; Paul S; Polanco P; Augustine M; Mansour J; Wang S; Porembka MR
J Gastrointest Surg; 2021 Jun; 25(6):1404-1411. PubMed ID: 32671798
[TBL] [Abstract][Full Text] [Related]
3. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative.
Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
Surg Oncol; 2020 Dec; 35():120-125. PubMed ID: 32871546
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
5. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
7. Racial and ethnic disparities in palliative care utilization among gynecological cancer patients.
Islam JY; Deveaux A; Previs RA; Akinyemiju T
Gynecol Oncol; 2021 Feb; 160(2):469-476. PubMed ID: 33276985
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis.
Wagle NS; Park S; Washburn D; Ohsfeldt R; Kum HC; Singal AG
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):463-470. PubMed ID: 38252039
[TBL] [Abstract][Full Text] [Related]
9. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
10. Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma.
Mokdad AA; Murphy CC; Pruitt SL; Mansour JC; Marrero JA; Singal AG; Yopp AC
Cancer; 2018 Feb; 124(4):743-751. PubMed ID: 29072773
[TBL] [Abstract][Full Text] [Related]
11. Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma.
Wagle NS; Park S; Washburn D; Ohsfeldt RL; Rich NE; Singal AG; Kum HC
Hepatol Commun; 2022 May; 6(5):1186-1197. PubMed ID: 34796703
[TBL] [Abstract][Full Text] [Related]
12. Disparities Associated With Inpatient Palliative Care Utilization by Patients With Metastatic Gynecologic Cancers: A Study of 3337 Women.
Rosenfeld EB; Chan JK; Gardner AB; Curry N; Delic L; Kapp DS
Am J Hosp Palliat Care; 2018 Apr; 35(4):697-703. PubMed ID: 29141457
[TBL] [Abstract][Full Text] [Related]
13. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
14. Differences in outcome for patients with cholangiocarcinoma: Racial/ethnic disparity or socioeconomic factors?
Lee RM; Liu Y; Gamboa AC; Staley CA; Kooby D; Russell MC; Cardona K; Maithel SK
Surg Oncol; 2020 Sep; 34():126-133. PubMed ID: 32891317
[TBL] [Abstract][Full Text] [Related]
15. Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database.
Hammad AY; Robbins JR; Turaga KK; Christians KK; Gamblin TC; Johnston FM
Ann Palliat Med; 2017 Jan; 6(1):26-35. PubMed ID: 28061532
[TBL] [Abstract][Full Text] [Related]
16. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
[TBL] [Abstract][Full Text] [Related]
17. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.
Robbins AS; Cox DD; Johnson LB; Ward EM
Cancer; 2011 Oct; 117(19):4531-9. PubMed ID: 21448933
[TBL] [Abstract][Full Text] [Related]
18. Insurance status impacts treatment for hepatocellular carcinoma.
Sobotka LA; Hinton A; Conteh LF
Ann Hepatol; 2019; 18(3):461-465. PubMed ID: 31040093
[TBL] [Abstract][Full Text] [Related]
19. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States.
Davila JA; Duan Z; McGlynn KA; El-Serag HB
J Clin Gastroenterol; 2012 Jan; 46(1):71-7. PubMed ID: 22157221
[TBL] [Abstract][Full Text] [Related]
20. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
